Use of cyclosporine MEPC (Neoral) in heart transplant recipients

被引：0
|
作者：
Fukushima, N [1 ]
Ohtake, S [1 ]
Sawa, Y [1 ]
Nishimura, M [1 ]
Kobayashi, Y [1 ]
Shirakura, R [1 ]
Nakata, S [1 ]
Matsuda, H [1 ]
机构：
[1] Osaka Univ, Sch Med, Dept Surg 1, Suita, Osaka 565, Japan
来源：
TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(98)01052-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3337 / 3338
页数：2
相关论文
共 50 条
  • [31] Influence of everolimus on cyclosporine neoral pharmacokinetics in Chinese de novo cardiac transplant recipients
    Wang, C. -H.
    Chou, N. -K.
    Wu, F-L. L.
    Ko, W. -J.
    Tsao, C. -I.
    Chi, N. -H.
    Hsu, R. -B.
    Wang, S. -S.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2032 - 2034
  • [32] Conversion from neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis
    Busque, S
    Demers, P
    St-Louis, G
    Boily, JG
    Tousignant, J
    Lemieux, F
    Smeesters, C
    Corman, J
    Daloze, P
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1247 - 1248
  • [33] SANDIMMUNE-NEORAL IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS WITH MALABSORPTION OF CYCLOSPORINE-A
    ATKISON, PR
    GRANT, DR
    WILLIAMS, SE
    HOWARD, J
    WALL, WJ
    STILLER, CR
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2953 - 2954
  • [34] Cyclosporine bioavailability of neoral and sandimmune in white and black de novo renal transplant recipients
    Pollak, R
    Wong, RL
    Chang, CT
    THERAPEUTIC DRUG MONITORING, 1999, 21 (06) : 661 - 663
  • [35] CRITERIA FOR USE OF CYCLOSPORINE IN ADULT TRANSPLANT RECIPIENTS
    NINNO, MA
    DAVIS, SK
    CLINICAL PHARMACY, 1993, 12 (09): : 696 - 698
  • [36] Safety and tolerability of Neoral in transplant recipients
    Feutren, G
    Wong, R
    Jin, J
    Niese, D
    Mellein, B
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2177 - 2182
  • [37] CHOLESTASIS IN HEART-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE
    SCHADE, RR
    GUGLIELMI, A
    VANTHIEL, DH
    THOMPSON, ME
    WARTY, V
    GRIFFITH, B
    SANGHVI, A
    BAHNSON, H
    HARDESTY, R
    TRANSPLANTATION PROCEEDINGS, 1983, 15 (04) : 2757 - 2760
  • [38] Conversion from sandimmune to neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption
    Chapman, JR
    OConnell, PJ
    Bovington, KJ
    Allen, RDM
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2293 - 2295
  • [39] Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus)
    Van Buren, D
    Payne, J
    Geevarghese, S
    MacDonell, R
    Chapman, W
    Wright, JK
    Helderman, JH
    Richie, R
    Pinson, CW
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1401 - 1402
  • [40] Conversion of cyclosporine (neoral;: CsA) to mycophenolate mofetil (MMF) in stable renal transplant recipients.
    Schrama, YC
    Hené, RJ
    Boer, P
    Koomans, HA
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1625 - 1626
12345